Security News
Biocon Launches Denosumab Biosimilars Bosaya™ / Aukelso™ in the United States
UnknownApr 21, 2026(5 days ago)
Biocon Launches Denosumab Biosimilars Bosaya™ / Aukelso™ in the United States
On April 7, 2026, Biocon announced the U.S. commercial launch of Bosaya™ / Aukelso™ (denosumab-kyqq), biosimilars of Amgen’s Prolia® / Xgeva® (denosumab).... By: Venable LLP